Epithelial Relaxation Mediated by the Myosin Phosphatase Regulator Mypt1 Is Required for Brain Ventricle Lumen Expansion and Hindbrain Morphogenesis by Gutzman, Jennifer H. & Sive, Hazel L.
 
 
1 
 
 
Epithelial relaxation, mediated by the myosin phosphatase regulator mypt1, is 
required for brain ventricle lumen expansion, and hindbrain morphogenesis. 
 
 
 
 
 
Jennifer H. Gutzman1 and Hazel Sive1,2† 
 
 
 
1Whitehead Institute for Biochemical Research 
Nine Cambridge Center, Cambridge, MA 02142 
and 2Massachusetts Institute of Technology 
77 Massachusetts Ave., Cambridge, MA 02139 
 
† corresponding author 
tel: 617-258-8242; fax: 617-258-5578; email: sive@wi.mit.edu 
 
Running Title:  MYPT1 and hindbrain morphogenesis 
Keywords: myosin, mypt1, neuroepithelium, rhombomere, brain ventricle, lumen, 
epithelial relaxation, morphogenesis, hindbrain, cell shape. 
 
 
2 
 
SUMMARY 
We demonstrate that, in the zebrafish hindbrain, cell shape, rhombomere morphogenesis, 
and unexpectedly, brain ventricle lumen expansion, depend on the contractile state of the 
neuroepithelium. The hindbrain neural tube opens in a specific sequence, with initial 
separation along the midline at rhombomere boundaries, subsequent openings within 
rhombomeres, and eventual coalescence of openings into the hindbrain ventricle lumen. 
A mutation in the myosin phosphatase regulator, mypt1, results in a small ventricle, due 
to impaired stretching of the surrounding neuroepithelium. Although initial hindbrain 
opening remains normal, mypt1 mutant rhombomeres do not undergo normal 
morphological progression. 3D reconstruction demonstrates cell shapes within 
rhombomeres and at rhombomere boundaries are abnormal in mypt1 mutants.  Wild type 
cell shape requires that surrounding cells be wild type, while mutant cell shape is 
autonomously regulated. Supporting the requirement for regulation of myosin function 
during hindbrain morphogenesis, wild type embryos show dynamic levels of 
phosphorylated myosin regulatory light chain (pMRLC). In contrast, mutants show 
continuously high pMRLC levels, with concentration of pMRLC and myosin II at the 
apical side of the epithelium, and myosin II and actin concentration at rhombomere 
boundaries. Brain ventricle lumen expansion, rhombomere morphology, and cell shape 
are rescued by inhibition of myosin II function, indicating that each defect is a 
consequence of overactive myosin. We suggest the epithelium must “relax”, via activity 
of myosin phosphatase, in order to allow for normal hindbrain morphogenesis and 
expansion of the brain ventricular lumen.  Epithelial relaxation may be a widespread 
strategy to facilitate tube inflation in many organs.  
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INTRODUCTION  
 
During vertebrate brain development, the lumen of the neural tube fills with 
embryonic cerebrospinal fluid (eCSF) to form the brain ventricles, a conserved system of 
interconnected cavities, essential for neurogenesis and normal brain function (Gato and 
Desmond, 2009; Lowery and Sive, 2009).  Brain ventricle formation is intimately 
connected to morphogenesis of the neuroepithelium. In the hindbrain, rhombomeres are 
segments of neurectoderm that differentiate into specific cranial nerves.  Rhombomeres 
are morphologically apparent during neural tube and initial brain ventricle formation, but 
concomitant with ventricle lumen expansion, rhombomeres lose morphological 
distinctness, although they retain different molecular identities (Hanneman et al., 1988; 
Heyman et al., 1993; Moens and Prince, 2002). 
Zebrafish mutants lacking eCSF fail to form a brain ventricular lumen, confirming 
the role of fluid secretion in inflating the ventricular lumen (Lowery and Sive, 2005). 
However, several zebrafish mutants with abnormal ventricle shape do not appear to have 
defects in eCSF secretion (Lowery et al., 2008). One such mutant corresponds to Mypt1, 
a regulatory inhibitor of myosin phosphatase. Myosin phosphatase regulates the 
phosphorylation state of myosin regulatory light chain (MRLC) which, in turn regulates 
contractility of non-muscle myosin II. In order for myosin phosphatase to be functional, 
Mypt1 must be non-phosphorylated, and bound to PP1 (the catalytic subunit of myosin 
phosphatase). Thus, phosphorylated Mypt1 inhibits myosin phosphatase activity 
(Hartshorne et al., 2004), and mutations in Mypt1 that prevent binding to PP1, result in 
non-functional myosin phosphatase (Huang et al., 2008).  
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Cell shape and movement are intimately correlated with myosin function (Lecuit 
and Lenne, 2007; Quintin et al., 2008). In Drosophila, myosin II is required for 
morphogenetic furrow formation during eye development and for regulation of cell shape 
and arrangement within the eye imaginal disc (Escudero et al., 2007).  Myosin II is 
required for proper sheet movement and cell shape during Drosophila dorsal closure 
(Mizuno et al., 2002; Tan et al., 2003). In zebrafish, Mypt1 is important for kidney 
formation and for convergent extension during gastrulation (Huang et al., 2008; Weiser et 
al., 2009).    
The role of myosin during vertebrate hindbrain formation is not understood. We 
demonstrate that regulation of myosin function through Mypt1, is required for normal 
hindbrain cell shape, rhombomere morphogenesis, and, unexpectedly, for brain ventricle 
lumen expansion, through a process we have termed “epithelial relaxation”.  This process 
may play a role during tube lumen expansion in multiple organs. 
 
 
MATERIALS AND METHODS 
Fish lines and husbandry 
Zebrafish were maintained and staged using standard procedures (Kimmel et al., 1995; 
Westerfield, 1995). Zebrafish lines included wild-type AB and mypt1hi2653 kindly 
provided by Nancy Hopkins (Amsterdam et al., 2004). Mutant identification information 
and primers are available upon request. 
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Brightfield brain imaging, ventricle injections, and forced neuroepithelial expansion 
Brain ventricle injections were carried out as described (Gutzman and Sive, 2009).  
Forced expansion was conducted as above with increased injection pressure (30 psi) for 
extended time and captured with video. The ventricle opening was measured at the ear 
before injection and at the point of maximal expansion during injection. 
 
Antisense morpholino oligonucleotide injections 
A splice site blocking morpholino-modified oligonucleotide (“morpholino”:MO) 5’-ATT 
TTT TGT GAC TTA CTC AGC GAT G 3’ (Gene Tools, LLC) which targets exon 2-
intron 2 of zebrafish mypt1 was injected into one-cell stage embryos.  Gene Tools 
standard 5'-CCT CTT ACC TCA GTT ACA ATT TAT A -3' was used as the control 
MO.   
 
Live confocal imaging 
Live embryo imaging was conducted as described (Gutzman et al., 2008).   Embryos 
were imaged by spinning disk laser microscopy (Perkin Elmer Ultraview RS) for time-
lapse experiments.  Images were analyzed using Imaris (Bitplane) or Photoshop (Adobe). 
 
Western blot analysis 
Wild type embryos were injected with 5 ng of either mypt1 splice site MO or control MO.  
The head/brain portion of each embryo was removed posterior to the ear and anterior to 
the first somite and collected in buffer containing 25mM Tris pH 8.0, 2mM EDTA pH 
8.0, 10% glycerol, 1% Triton X-100 plus protease inhibitor. Phospho-MRLC (Cell 
 
 
6 
 
Signaling, #3671, 1:1000), β-actin (Sigma, A5441, 1:1000). Films were scanned and 
quantified using Photoshop (Adobe).  
 
Immunohistochemistry 
Embryos were fixed in Dents (myosin II) or in 4% paraformaldehyde (phosphorylated 
MRLC), blocked in 5% NGS in PBT, incubated in primary antibody (Anti-myosin IIA, 
M 8064, Sigma, 1:500; phospho-MRLC #3671, Cell Signaling, 1:20) and incubated in 
secondary antibody (goat anti-rabbit or anti-mouse IgG Alexa Flour 488, Invitrogen, 
1:500), some in combination with propidium idodide (PI) (Invitrogen P3566, 1:1000).  
Actin staining was conducted as previously described (Gutzman et al., 2008). Images 
were analyzed using Imaris (Bitplane), LSM software (Zeiss), and Photoshop (Adobe).  
For vibratome sections, fixed embryos were embedded in 5% low-melt agarose. 50 µm 
sections were stained as described above.   
 
Mosaic analysis 
Wild type embryos were co-injected with 5ng control MO or 5ng mypt1 MO and either 
memCherry (kindly provided by Dr. Roger Tsien, University of California San Diego) or 
memGFP mRNA at the one-cell stage.  Cells were transplanted from the memGFP 
injected donors at sphere stage to memCherry injected hosts at shield stage targeted to the 
presumptive hindbrain (Woo and Fraser, 1995).  Transplanted embryos were imaged at 
19 hpf by scanning confocal microscopy.  
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3D cell reconstruction 
Confocal images were imported into 3D Doctor (Able Software Corp.).  Single cells in r4 
and at the r4/r5 boundary were chosen to reconstruct in 3D based on the ability to see an 
entire cell from the apical to basal side of the neuroepithelium through a z series.  
Individual cells were manually outlined in each z-section and rendered in 3D. For mosaic 
analysis, transplanted cells were reconstructed using automated surface rendering of the 
green channel (transplanted cells) in Imaris (Bitplane). 
 
Blebbistatin treatment  
Wild type and mypt1 mutant embryos were treated with either 50 µm blebbistatin (B0560 
Sigma) or 0.1% DMSO control at 22 hpf.  After treatment embryos were imaged by brain 
ventricle injection (Gutzman and Sive, 2009).  Or, an mypt1 mutant clutch of embryos 
was treated with 50 µm blebbistatin or 0.1% DMSO at 17 hpf.  Embryos were imaged at 
19 hpf and then collected and analyzed for genotype following imaging. 
 
Quantitation of neuroepithelial width 
Width of the neuroepithelium was measured from the apical midline of one side of the 
neural tube to the basal edge of the neural tube using 3D doctor (Able Software Corp.). 
Measurements were taken at the widest region of rhombomere 4 or the r4/r5 boundary. 
All measurements were done in a single plane of section at a depth located at the apical 
edge of the developing ear. 
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RESULTS 
 
A specific sequence of hindbrain ventricle opening  
As the brain ventricles form, the closed zebrafish neural tube must separate at the 
midline and undergo lumen expansion as it fills with eCSF (Lowery and Sive, 2005).  In 
order to determine how these separation and expansion processes occur, we analyzed the 
temporal sequence of neural tube opening during formation of the hindbrain ventricle. In 
all vertebrates, the hindbrain neuroepithelium is divided into segmented rhombomeres, 
transient anteroposterior bulges (Lumsden, 2004; Vaage, 1969), with distinct gene 
expression and fates.  Our focus was on a seven-hour period during zebrafish brain 
development, 17-24 hours post fertilization (hpf), beginning after completion of 
neurulation, encompassing the time of initial neural tube opening, neuroepithelial 
morphogenesis, and ventricle expansion. Emphasis was on the hindbrain, since this forms 
the largest ventricle. The sequence of hindbrain opening is shown in live embryos, 
imaged by spinning disk confocal (Fig. 1 and Supplemental Movie 1). At 17 hpf the 
neural tube has formed a clear midline, and outlines of rhombomeres (r) are apparent as 
shallow indentations on the outside of the neural tube (Fig. 1A).  An initial hindbrain 
opening was present at approximately 18 hpf, between the boundary of rhombomere 0 
(r0) and rhombomere 1 (r1) (Fig. 1B); therefore, we hypothesized that ventricle inflation 
would occur in an anterior to posterior direction. However, by 19 hpf, when 
rhombomeres were clearly visible, additional openings appeared at the r3/r4 boundary 
and the r4/r5 boundary, in the middle of the hindbrain (Fig. 1C). The openings 
surrounding r4 were consistent with reported r4 determination, as determined by gene 
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expression, and the sequence of visible rhombomere boundary morphology in the 
zebrafish (Maves et al., 2002; Moens and Prince, 2002).  By 20 hpf, the lumen of the 
neural tube had begun to open anteriorly and posteriorly from r1, while a new opening 
was seen at the r2/r3 boundary (Fig. 1D). By 21 hpf, the lumen was open within r2 (Fig. 
1E), while by 22 hpf lumen opening was seen within r4, leaving the only visible 
rhombomere morphology at r3 and r5, the two largest rhombomeres (Fig. 1F).  Between 
23 and 24 hpf, separation of r3 and r5, occurred and the ventricle lumen expanded (Fig. 
1G,H). Thus, by 24 hpf, the neural tube was open with a large ventricular space. The 
more posterior rhombomeres, r6 and r7, opened in a sequence that was consistent with 
rhombomere determination by gene expression (data not shown); however, due to the 
curvature of the embryo, we could not image the entire length of the hindbrain in any one 
experiment, and focused on more anterior rhombomeres. 
These data show that, contrary to our hypothesis, the hindbrain ventricle does not 
open in an anterior to posterior sequence. Rather, opening occurs in a stereotypical 
sequence along the length of the hindbrain, with initial openings between rhombomeres, 
and later coalescence of these openings to form the hindbrain ventricle lumen.  
 
mypt1 mutants have abnormal hindbrain ventricle expansion and retain early 
rhombomere morphology 
In order to define the mechanisms underlying hindbrain ventricle opening and 
expansion, we focused on the mypt1hi2653 insertional mutant, identified as having small 
and abnormally shaped brain ventricles (Amsterdam et al., 2004; Lowery and Sive, 
unpublished).  The retroviral insertion is located in the mypt1 gene (also called ppp1r12a) 
encoding the protein myosin phosphatase subunit 1 (Mypt1), a required regulator of the 
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myosin phosphatase holoenzyme (Ito et al., 2004; Matsumura and Hartshorne, 2008) (see 
Fig. S1 A,B in supplementary material). Gene assignment for mypt1hi2653 was confirmed 
by rescue of mutants with wild type mypt1 mRNA, by RT-PCR for mypt1 mRNA in 
mutants (see Fig. S1C,D in supplementary material), and by injection of a mypt1 splice 
site morpholino-modified oligonucleotide (“morpholino”:MO), and rescue of the 
phenotype (see Fig. S1E-G in supplementary material).  mypt1 is expressed maternally 
and zygotically throughout the embryo (see Fig. S2 in supplementary material).  The 
events we describe occur prior to the onset of heartbeat, indicating that circulation is not 
involved.  
In brain ventricles injected with Texas Red dextran (Gutzman and Sive, 2009) at 
the early stages of hindbrain opening (18-21 hpf), mypt1 mutants appeared the same as 
wild type (see Fig. S3 in supplementary material).  However, by 24 hpf, mypt1 mutants 
had defects in brain structure (Fig. 2A-D), and dorsal images showed that specific regions 
of the hindbrain remained apposed, without ventricle expansion (Fig. 2A,B). Strikingly, 
while lateral views showed that rhombomere morphology was not visible in wild type 
embryos, distinct rhombomeres were visible in mypt1 mutants (Fig. 2C-F). 
The mypt1 mutant phenotype was examined more closely by high-resolution 
confocal live imaging at 18, 21, and 24 hpf.  Wild type and mypt1 mutants appeared 
grossly similar at 18 hpf, although the neural tube was narrower (Fig. 2G,H), while at 21 
hpf, hindbrain openings at rhombomere boundaries (r3/r4 and r4/r5) were present in both 
mutant and wild type, indicating that steps in initial hindbrain opening occurred normally 
(Fig. 2I,J). However, at 24 hpf, although the neural tube had opened in mypt1 mutants, 
the hindbrain ventricle was poorly expanded relative to wild type (Fig. 2K,L’). Consistent 
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with brightfield imaging, by 24 hpf, wild type embryos had lost distinct rhombomere 
morphology, whereas in mutants, rhombomere morphology persisted (compare Fig. 
2K,K’ with Fig. 2L,L’).  
We excluded the possibility that mypt1 phenotypes were consequences of changes 
in cell death or cell proliferation using TUNEL and PH3 staining (see Fig. S4 in 
supplementary material).  In addition, rhombomeric gene expression patterns progressed 
normally, as did expression of the post-mitotic neuronal marker HuC, in mypt1 mutants, 
indicating that the phenotypes are specific to morphogenesis  (see Fig. S5 in 
supplementary material).   
The mypt1 mutant ventricle could have expanded poorly either because too little 
eCSF was produced, or because the neuroepithelium was incapable of expanding fully. 
We therefore asked how much the mutant and wild type hindbrain ventricles could be 
forced to open, by high pressure injection (30psi) of fluid into the ventricle (Fig. 2M).  In 
wild type embryos, hindbrain ventricle width could be increased by 1.5 fold relative to 
the uninjected ventricle (Fig. 2N and Fig. S6 in supplementary material). However, in 
mutants, hindbrain ventricle width could be maximally increased by only 1.3 fold relative 
to its original size.  Thus, the mypt1 mutant neuroepithelium was less able to expand than 
wild type.  
In sum, our data show that in the mypt1 mutant, a clear hindbrain phenotype is 
apparent by 24 hpf, after the hindbrain ventricle has opened. Rhombomere morphology 
does not progress normally, and the hindbrain ventricle is poorly expanded. The data 
demonstrate that the mutant neuroepithelium is unable to stretch as much as wild type, 
explaining the small hindbrain ventricle lumen in mypt1 mutants. 
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mypt1 mutants have abnormally shaped neuroepithelial cells 
The persistence of rhombomere morphology in mypt1 mutants led us to ask 
whether mutant hindbrain cell shape was abnormal. Scanning confocal imaging at 
cellular resolution was performed in wild type and mutant embryos at 19 hpf, when the 
neuroepithelial cells are aligned so that the entire length of the cell can be imaged. At 
later stages, neuroepithelial cells are tilted and the full length of a cell is difficult to 
capture. r4, r5 and the r4/r5 boundary were imaged, and 3D cell shapes were 
reconstructed as described in Methods.  
In wild type embryos, cells within the rhombomeres were spindle-shaped that is, 
narrow apically and basally.  In contrast, boundary cells, between rhombomeres, were 
club shaped: wide at either the apical or basal end and long and narrow at the other  (Fig. 
3A-C and Fig. S7 in supplementary material).  In contrast to wild type, mypt1 mutant 
cells within rhombomeres were shorter and wider, and lacked the narrow ends (Fig. 3D-F 
and Fig. S7 in supplementary material). Cells at the r4/r5 boundary were also shorter and 
wider, without the characteristic wild type club shape (Fig. 3D-F and Fig. S7 in 
supplementary material).   
Since mypt1 is broadly expressed, we asked whether the mypt1 mutant phenotype 
was a result of activity within the neuroepithelium, or whether surrounding tissues 
directed the mutant phenotype. In addition, we asked whether the phenotype within the 
neuroepithelium was cell autonomous. These questions were addressed using transplants 
of late blastula cells from mypt1 or control morpholino injected embryos into the 
presumptive hindbrain region of gastrula stage wild type or mypt1 embryos (Woo and 
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Fraser, 1995).  Transplanted cells within the hindbrain were assayed for cell shape at 19 
hpf.  mypt1 morphant cells transplanted into a control morphant host showed mutant 
morphology in both intra-rhombomere and rhombomere boundary cells (Figure 3G-I), 
indicating that Mypt1 functions cell-autonomously in the hindbrain.  However, control 
cells transplanted into mypt1 morphant hosts adopted mypt1 mutant cell shapes (Figure 
3J-L), demonstrating that wild type cell morphology requires surrounding wild type cells.  
Consistently, transplants of control cells into control hosts showed wild type cell shapes 
(Figure 3M-O). In all cases assayed, transplanted cells were present only in the 
neuroepithelium, and not in epidermal, mesodermal or endodermal cells, indicating that 
surrounding tissues do not influence neuroepithelial cell shape. 
 These data show that the characteristic cell shapes within and between wild type 
rhombomeres are not present in mypt1 mutants.  These abnormalities occur early, before 
failure of ventricle expansion or failure of rhombomere progression. Wild type cell shape 
requires a surrounding cohort of wild type cells, whereas mutant cell shape is manifest 
cell autonomously. 
 
Phosphorylation of myosin regulatory light chain is abnormally elevated and 
apically localized in the developing brain of mypt1 mutants 
Active myosin phosphatase dephosphorylates myosin regulatory light chain 
(MRLC) (Ito et al., 2004). Dephosphorylation of MRLC inactivates non-muscle myosin 
II, and limits contraction (Fig. 4A). Based on this scheme, and knowing that the mutation 
in Mypt1 would disrupt the binding of Mypt1 and PP1 and render myosin phosphatase 
inactive, we hypothesized that phosphorylated MRLC (pMRLC) levels would be higher 
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in mypt1 mutant brains relative to wild type. The level of pMRLC was examined in brain 
tissue, microdissected from 18, 21 and 24 hpf embryos (Fig.4B), with or without Mypt1 
function. In order to obtain enough brain tissue for analysis by Western blot, we used 
morpholino injected embryos for these experiments.  
At all time points, pMRLC levels were 3-5 fold higher in embryos injected with 
the mypt1 MO than in control embryos (Fig. 4C,D). Further, the level of pMRLC in 
control embryos changed with time, such that pMRLC levels peaked at 21 hpf, and were 
2.5-fold lower at 18 hpf and 24 hpf (Fig. 4E).  These data show that pMRLC levels 
change during normal brain development, and that in the mypt1 mutant, very high levels 
of pMRLC are present throughout hindbrain ventricle opening.  
These changes in pMRLC levels prompted us to ask where pMRLC is localized. 
Immunocytochemistry was performed on wild type siblings and mypt1 mutants at 19, 21, 
and 24 hpf, pMRLC (Fig. 4F-Q). In wild type embryos at 19 hpf, pMRLC was localized 
on the basal side of the neural tube, with some apical localization, and diffuse expression 
throughout the cells (Fig. 4F,G). At 21 hpf, pMRLC expression appeared stronger 
apically, consistent with Western blot data (Fig. 4H,I), and by 24 hpf, apical staining had 
disappeared (Fig. 4J,K). In mypt1 mutants, apical pMRLC staining was very strong at all 
time points assayed (Fig. 4L-Q). Similar to wild type, mypt1 mutants showed basal 
pMRLC immunostaining (Fig. 4L-Q). 
These data show that, in wild type embryos, phosphorylation of MRLC is 
dynamic - peaking during neural tube opening and then falling to lower levels as the 
hindbrain ventricle opens. In contrast, mypt1 mutants show strongly elevated, apically 
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localized, pMRLC expression, indicating that Mypt1 regulates both pMRLC levels and 
localization in the developing brain.  
 
Non-muscle myosin concentrates apically, and both non-muscle myosin II and actin 
are concentrated at rhombomere boundaries in mypt1 mutants 
 Myosin regulatory light chain is bound at the head region of myosin to form the 
non-muscle myosin II functional unit (Landsverk and Epstein, 2005); therefore, increased 
apical pMRLC in mypt1 mutants may lead to apical concentration of non-muscle myosin 
II (myosin heavy chain).  To test this, we performed immunostaining for myosin II on 
wild type and mypt1 mutants (Fig. 5). At all stages, myosin II is present basally and 
within cells. 19 hpf wild type and mypt1 mutant embryos show a similar pattern of 
myosin II localization in the brain while at 21 hpf, mypt1 mutants show slightly increased 
staining of myosin II at the apical surface of the neuroepithelium compared to wild type 
(see Fig. S8 supplemental material). However, while in 24 hpf mypt1 mutants show much 
stronger apical myosin II staining than wild type (Fig. 5A-C,G-I).  
In order to examine the apical surface of the rhombomeres more closely, we 
removed the roofplate and flat mounted the neural tube (see diagram Fig. 5F). Strikingly, 
in mypt1 mutants, but not in wild type, myosin II staining was present at the rhombomere 
boundaries, in a line along the apical surfaces of boundary cells (Fig. 5D, arrows in Fig. 
5E). This staining was consistent with persistence of rhombomere morphology in mypt1 
mutants.  
We also analyzed localization of actin, another critical component of the 
cytoskeleton, which interacts with myosin (Lecuit and Lenne, 2007).  In wild type 
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embryos, actin surrounded cells and was concentrated at the apical cell surfaces lining the 
brain ventricle, consistent with actin localization at adherens junctions (Fig. 5J,M and 
diagrams in L,O).  The levels and apical localization of actin did not appear altered in 
mypt1 mutants (Fig. 5N).  However, dorsal 3D projection views of mypt1 mutant embryo 
hindbrain showed strong accumulation of actin at rhombomere boundaries (arrows Fig. 
5K), consistent with myosin II localization.   
These data indicate that in mypt1 mutants, non-muscle myosin II, along with 
pMRLC, is concentrated apically in the hindbrain neuroepithelium. Non-muscle myosin 
II and actin are abnormally localized at rhombomere boundaries, suggesting that this may 
be responsible for failure of rhombomere morphology progression. 
 
Abnormal ventricle morphogenesis in mypt1 mutants is myosin dependent 
We used an independent approach to ask whether over active myosin was 
responsible for the mypt1 mutant phenotype, asking whether the myosin II inhibitor, 
blebbistatin (Kovacs et al., 2004) would rescue the hindbrain ventricle phenotype (Fig. 
6A,B). At 22 hpf, mutant or wild type embryos were treated with DMSO as a control, or 
50 µm blebbistatin.  After 3 hours of treatment, embryos were ventricle injected and then 
imaged (Fig. 6C-J). Blebbistatin slightly reduced the size of the wild type hindbrain 
ventricle (Fig. 6E,F), but did not alter rhombomere morphology.  However, blebbistatin 
treatment fully rescued the mypt1 mutant phenotype (Fig. 6I,J), with the hindbrain 
ventricle fully open, and rhombomere morphology no longer apparent.  Other phenotypes 
in the mutant embryo were also rescued, including the abnormal notochord and somites 
(Fig. 6G,H).  Additionally, the inability of mypt1 mutant neuroepithelium to fully expand 
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when forced open with high pressure injection (Fig. 2N) was also rescued by blebbistatin 
treatment (see Fig. S9 in supplementary material). These data confirm that the mypt1 
phenotype is a result of overactive myosin contraction, and that myosin II inactivation is 
required for hindbrain morphogenesis and full ventricle expansion. 
 
mypt1 neuroepithelial cells are abnormally shaped due to myosin contraction 
We extended this analysis (Fig. 3) to ask whether blebbistatin would correct 
mutant cell shape. A mypt1 mutant clutch of embryos was injected with memGFP mRNA 
and treated with 50 µm blebbistatin at 17 hpf. At 19hpf, embryos were imaged, and 3D 
cell shapes were reconstructed. Since the mutant phenotype is not grossly visible at this 
time, embryos were genotyped by PCR (Fig. 7A). mypt1 mutants treated from 17 hpf to 
19 hpf with blebbistatin showed normal cell shapes within and between rhombomeres 
(compare Fig. 7c,d and g,h).   
As a corollary to cell shape changes, we quantified the width of the 
neuroepithelium in all treatment groups, by measuring the distance from the apical side of 
the epithelium to the basal side at r4 and at the r4/r5 boundary.  In mypt1 mutants, tube 
width was significantly (13%) narrower than in wild type embryos at r4 and at the r4/r5 
boundary (10%) (Fig. 7C and Fig. S10 in supplementary material). In mypt1 mutants 
treated with blebbistatin, neural tube width was restored to the wild type width (Fig. 7C 
and Fig. S10 in supplementary material).     
These data demonstrate that hindbrain cell shape and neural tube width, is 
regulated by myosin activity.   
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DISCUSSION 
 
Cell shape, rhombomere morphogenesis and ventricle expansion are regulated by 
myosin contractility  
We demonstrate for the first time, that modulation of myosin activity by myosin 
phosphatase affects three aspects of normal hindbrain development: neuroepithelial cell 
shape, morphogenesis of the rhombomeres and expansion of the hindbrain ventricle (Fig. 
8). Of particular significance is our finding that, unless myosin contractility is reduced, 
the lumen of the neural tube cannot expand to form the normal hindbrain ventricle.   
 
Regulation of neuroepithelial cell shape via apical modulation of myosin function 
The earliest hindbrain phenotype we observed in mypt1 mutants was abnormal 
cell shape. Spindle shaped rhombomeric cells and club-shaped boundary cells lost their 
characteristic shapes with inhibition of mypt1 and overactive myosin. It is not clear what 
normally drives formation of these disparate shapes; however, cells within rhombomeres 
are more adhesive than those between (Cooke et al., 2005), perhaps contributing to cell 
shape differences. Mosaic analysis showed that mypt1 mutant cells always assumed 
mutant shape, regardless of the genotype of the surrounding cells, indicating cell 
autonomous Mypt1 function. However, wild type cell shape required that surrounding 
cells also be wild type, suggesting a non-autonomous function. One possible explanation 
for these results is that wild type cells cannot push or pull enough against the stiff mypt1 
neuroepithelium to realize their normal shapes. Another possibility is that wild type cells 
must be fully connected through junctions in the epithelial sheet in order to undergo 
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correct shape change. Interestingly, a similar duality of cell-autonomous and non-
autonomous phenotype was also observed for mypt1 function during convergent 
extension (Weiser et al., 2009)  
Loss of asymmetric shape in cells with overactive myosin raises the question of 
whether Mypt1 acts through the apical or basal side of the cell. In embryos lacking mypt1 
function, the pMRLC was concentrated at the apical surface of the neuroepithelium. 
Since the strong expression of pMRLC and myosin II basally appeared unaltered after 
mypt1 loss of function, the effects of Mypt1 are likely mediated through the apical side of 
the epithelium. 
  Consistent with regulation of cell shape via apical myosin activity, Kinoshita et al. 
demonstrated Rho localization at the apical surface of the epithelium during chick 
neurulation, and connected some of its effects with pMRLC (Kinoshita et al., 2008). In 
the developing Drosophila eye, myosin II regulates changes in both cell shape and cell 
clustering, and in spaghetti squash (MRLC mutant) and zipper (myosin heavy chain 
mutant) the apical surface does not constrict (Escudero et al., 2007; Hildebrand, 2005; 
Lee and Treisman, 2004).  
 
Sequence of hindbrain opening, and rhombomere progression 
A later phenotype in the mypt1 mutant was failure of rhombomeres to progress 
through their normal sequence of morphogenesis, whereby rhombomere morphology is 
lost over the six-hour time period we analyzed.  This progression is dependent on 
inhibition of myosin activity, and coupled to the normal dynamic changes in pMRLC 
levels, which peak as the neural tube midline separates, and decrease as rhombomere 
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morphology progresses. During the time period when rhombomere morphology would 
normally have been lost, in the mypt1 mutant, myosin II and actin were strongly 
concentrated at rhombomere boundaries, and not visible at wild type boundaries. Thus, 
an overactive actinomyosin network at the rhombomere boundaries in the mypt1 mutant 
may hold the rhombomeres in their morphologically segmented state.  
Failure of morphological rhombomere progression in mypt1 mutants was 
independent of the changes in gene expression characteristic of differentiating 
rhombomeres, indicating that morphology, and not cell type determination, is under 
actinomyosin regulation. This failure of rhombomere progression is also independent of 
fluid pressure within the ventricle space as snakehead mutants lacking embryonic 
cerebrospinal fluid do not have arrested rhombomere morphology (Lowery and Sive, 
2005). Further, the mypt1 phenotype did not involve control of cell number, since neither 
cell proliferation, nor cell death was affected, further pointing to myosin contractility as 
the major player in this morphogenetic change. 
  
“Epithelial relaxation” and the role of myosin in ventricle expansion   
Opening of the hindbrain ventricle along the neural tube midline begins normally 
in mypt1 mutants, but later, the ventricle does not expand completely as a result of a 
“stiff” mutant neuroepithelium.  
In many organs (for example, McCray et al., 1992), tubes initially form without a 
lumen, or with only a small lumen, which must expand to allow the tube to function.  Part 
of this expansion is through fluid secretion, and in the embryonic brain, the ventricular 
lumen expands as it fills with eCSF (Lowery and Sive, 2009).  However, this study shows 
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that ventricular lumen expansion also requires a stretchy neuroepithelium, which can 
expand appropriately with eCSF. We have coined the term “epithelial relaxation” to 
describe the acquisition of stretchiness, which depends upon inhibition of myosin 
contractility, and suggest that this may be a widespread mechanism underlying expansion 
of epithelial tubes in other organs. 
 How would myosin activity regulate cell stretching, or elasticity? Elasticity of a 
cell is determined by the cytoskeleton, primarily through the cortical actinomyosin 
network.  Cortical tension is created when myosin II contracts, pulling actin filaments 
together (Clark et al., 2007).  In mypt1 mutants, cortical actin localization does not 
change, except at rhombomere boundaries, but the excessive myosin contraction would 
increase cytoskeletal tension in all cells, resulting in a more rigid, less “stretchy” cell, and 
a less elastic neuroepithelium.  Our data complement the observation that earlier, myosin 
is required for neural plate stiffness during neurulation in Xenopus (Rolo et al., 2009).  
After neurulation, myosin function must be suppressed to increase stretchiness of the 
neuroepithelium, enabling the hindbrain ventricle to expand. 
Another consideration is that, because cells are connected by junctions, the 
neuroepithelium may act as a unit during morphogenesis and ventricle formation 
(Lowery and Sive, 2009). In tissue culture cells, Mypt1 interacts with ERM proteins in 
the apical junction complex (Eto et al., 2005; Kawano et al., 1999), suggesting that apical 
junctions may be abnormal in the mypt1 mutant. However, immunostaining with several 
apical junction markers showed no abnormalities in the mutants described here (Figure 5 
and data not shown). 
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Epithelial relaxation has not previously been described during development, but 
may be similar to the changes in contraction and relaxation of tubes that are surrounded 
by smooth muscle.  Like non-muscle myosin, smooth muscle is also regulated by Mypt1 
and myosin phosphatase (Pfitzer, 2001), and, processes akin to epithelial relaxation may 
exist in vascular smooth muscle (Hirano, 2007), smooth muscle of the urinary bladder 
(Ding et al., 2009; Poley et al., 2008), gastrointestinal smooth muscle (Huang et al., 2005; 
Ihara et al., 2007), and secretion of bile by the gall bladder (Camello-Almaraz et al., 
2009).   
 
Is there a connection between all mypt1 hindbrain phenotypes? 
  Downstream of myosin function, it is not clear whether each of the events 
described is under the same molecular control, and whether one of these events affects 
another. For example, cell shape abnormalities are the earliest phenotypes we observe in 
the mypt1 mutant. Do these abnormally shaped cells contribute to a failure of 
rhombomere morphology progression, or to failure of the hindbrain ventricle to expand? 
Since myosin II and actin accumulated at rhombomere boundaries, excess contraction 
along a line of boundary cells, in effect functioning as a unit, may prevent progression of 
rhombomere morphogenesis. Thus, rhombomere progression may correlate with 
abnormally shaped cells, but may not be caused by the abnormal cell shape, per se. With 
regard to ventricle opening, we believe it is most relevant to view this process as a result 
of epithelial sheet activity, rather than as dependent on individual cell shape. However, 
mypt1 mutant cells may be more rigid than wild type cells, and, as a group, may 
contribute to epithelial “tightness” and failure of hindbrain ventricle expansion. Are 
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rhombomere progression and ventricle opening linked? In wild type embryos, 
rhombomere progression and ventricle expansion both occur as pMRLC levels decline, 
but it is unclear whether these events are interdependent. Future studies will focus on 
additional mechanisms underlying epithelial relaxation, the connection between the 
events described here, and the regulation of mypt1 activity in the neuroepithelium.  
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FIGURE LEGENDS 
Fig. 1.  The sequence of wild type hindbrain ventricle opening.  (A-H) Time course of 
wild type hindbrain ventricle opening from 17 hpf to 24 hpf.  Embryos were injected with 
memGFP mRNA (n=12).  Model images are a representative snapshot of the hindbrain 
opening at each time point.  (A) 17 hpf, the neural tube is closed with visible 
rhombomere morphology.  (B) 18 hpf, the initial opening is visible at the r0/r1 boundary.  
(C) 19 hpf, openings surrounding r4 are visible. (D) 20 hpf, there are openings at the 
r2/r3 boundary and r1 has separated completely.  (E) 21 hpf, opening within r2 occurs.  
(F) 22 hpf, separation within r4 has occurred.  (G) 23 hpf, separation within r3 has 
occurred.  (H) 24 hpf, separation within r5 occurs resulting in an open ventricle and less 
prominent rhombomere morphology. Asterisks denote the ear.  Arrowheads indicate 
regions that are separating.  r0-r5 indicate specific rhombomeres.  Anterior is to the left. 
 
Fig. 2.  mypt1 mutant phenotype.  (A-F) 24 hpf wild type and mypt1 mutant brain 
ventricle injections.  Wild type (A) and mypt1 (B) dorsal views.  Wild type (C) and mypt1 
(D) lateral views. (E-F) Higher magnification of boxed region in C and D respectively.  
Arrowheads indicate rhombomere boundaries.  (G-L’) Live confocal imaging of the 
hindbrain in wild type (G,I,K,K’) and mypt1 mutants (H,J,L,L’) after memGFP mRNA 
injection.  (G,H) 18 hpf, wild type and mypt1 mutants respectively.  (I,J) 21 hpf, wild 
type and mypt1 mutant respectively with similar morphology and hindbrain openings (see 
arrows).  (K,L) 24 hpf wild type and mypt1 mutant respectively.  (K’-L’) are the same 
image as in K and L respectively with neuroepithelial tissue outlined in yellow. Dotted 
lines denote rhombomere morphology (L’) (n>10 for all panels).  mypt1 mutants have a 
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normal neural tube, suggesting maternal gene expression is sufficient for brain 
development until the end of neurulation. Consistent with this, inhibition of Mypt1 
expression using a start site MO led to a disorganized neural tube (data not shown), 
whereas a splice site MO (see Fig. S1 in supplementary material) showed a phenotype 
only after the neural tube had formed. (M) Schematic of the hindbrain “before” and at 
“maximum” forced ventricle expansion, a and b indicate regions that were measured.  
(N) Quantitation of the expandability of the hindbrain neuroepithelium in wild type and 
mypt1 mutants. Two independent experiments were averaged, wt n=12, mypt1 n=15. Data 
are represented as an Expansion Ratio +/- standard deviation.  Bars are significantly 
different using the Mann-Whitney U test p<0.001. Asterisks denote the ear. r0-r5 label 
specific rhombomeres.  Anterior is to the left.  H=hindbrain ventricle.  Scale bars A-
F=100µm, G-L’=50µm. 
 
Fig. 3. Abnormal cell shape in mypt1 mutants and cell shape mosaic analysis. (A-F) 
Wild type and mypt1 mutant embryos injected with memGFP mRNA and confocal 
imaged.  Single cells were traced through a z-series then reconstructed in 3D.  (A) 19 hpf 
wild type embryo. (B) Same image as in A with three cells outlined shown in one z-
plane. (C) 3D shape of the cells shown in panel B. (D) 19 hpf mypt1 mutant embryo. (E) 
Same image as in D with three cells outlined shown in one z-plane. (F) 3D shapes of cells 
shown in panel E.  Rhombomeres are outlined in yellow dotted lines and boundary cells 
are visible between rhombomeres (A,D). Red=dividing cell, yellow=rhombomere cell, 
blue=boundary cell. Wild type and mypt1 mutant dividing cells were similar in shape. 
Each image is representative from 3 independent experiments, at least 3 embryos were 
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imaged and 3-5 cells were reconstructed in 3D for each embryo, per experiment.  (G-O) 
Wild type embryos were injected with control MO or mypt1 MO and memCherry or 
memGFP mRNA as indicated.  Cells were transplanted from the memGFP injected 
donors to memCherry injected hosts.  Transplanted embryos were imaged at 19 hpf by 
scanning confocal microscopy.  (G-H)  Control MO injected host (red) with mypt1 MO 
donor cells (green). (I) 3D shape of transplanted donor cells. (J-K) mypt1 MO injected 
hosts (red) with control MO donor cells (green). (L) 3D shape of transplanted donor cells. 
(M-N) Control MO injected host (red) with control MO donor cells (green). (O) 3D 
shape of transplanted donor cells. Cells were reconstructed in 3D using Imaris.  
Rhombomeres are outlined in yellow (G,J,M) Each image is representative of at least 3 
independent experiments where at least 3 embryos were imaged. 3 or more cells were 
reconstructed in 3D for each embryo per experiment.  Scale bars=25µm.  
 
Fig. 4. pMRLC is abnormally elevated and persists apically in the developing brain 
of mypt1 mutants.  (A) Model of Mypt1 as part of myosin phosphatase.  (B) Hypothesis 
model for mypt1 mutant myosin phosphatase. (C) Western blot of brain tissue dissected 
from embryos at 18, 21, and 24 hpf after injection with control MO or mypt1 splice site 
MO with actin control. Approximately 100 brains were dissected for each treatment 
group and 50µg of protein was analyzed. (D) Quantitation of fold changes of pMRLC 
normalized to actin at 18 hpf comparing control MO injected to mypt1 MO injected 
embryos. Three independent experiments.  (E) Quantitation of fold changes of pMRLC 
normalized to actin over time in control MO embryos. Three independent experiments.  
(F-Q) Transverse vibratome sections through the hindbrain of embryos stained with 
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pMRLC (green), and counterstained nuclei with propidium iodide (red). Representative 
images from 4 independent experiments, 2-3 embryos were imaged at each stage per 
experiment.  (F) Wild type embryo at 19 hpf.  (G) Higher magnification of the region 
indicated in F.  (H) Wild type embryo at 21 hpf. (I) Higher magnification of the region 
indicated in H.  (J) Wild type embryo at 24 hpf. (K) Higher magnification of the region 
indicated in J.  (L) mypt1 mutant embryo at 19 hpf. (M) Higher magnification of the 
region indicated in L.  (N) mypt1 mutant embryo at 21 hpf.  (O) Higher magnification of 
the region indicated in N.  (P) mypt1 mutant at 24 hpf. (Q) Higher magnification of the 
region indicated in P.  Dorsal is to the top. Arrows point to the apical neuroepithelial 
surface in all images.  F,H,J,L,N,P scale bars=50µM;  G,I,K,M,O,Q scale bars=10µM. 
 
Fig. 5.  Abnormal localization of non-muscle myosin II and actin in mypt1 mutants.  
(A-I) Wild type and mypt1 mutant embryos were stained with non-muscle myosin II 
antibody (green) and counterstained with propidium iodide to label nuclei (red).  
Representative images from 4 independent experiments.  For each experiment 2-3 
embryos were imaged.  (A-B) 3D projection of a whole mount wild type (A) or mypt1 
mutant (B) at 24 hpf. (C) Diagram of region imaged in A and B. (D-E) Wild type (D) and 
mypt1 mutant (E) at 24 hpf mounted after removal of the roof plate imaging the region 
shown in the small box in A labeled D’ (wild type) or in B labeled E’ (mypt1 mutant). (F) 
Diagram of region imaged in D and E.  (G-H) Vibratome section of a 24 hpf wild type 
(G) or mypt1 mutant (H) embryo. (I) Region of the embryo sectioned for G and H. (J-O) 
Wild type and mypt1 mutants stained with phalloidin (green). Representative images 
from 2 independent experiments.  For each experiment 3-4 embryos were imaged. (J-K) 
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3D projection of a whole mount wild type (J) or mytp1 mutant (K) at 24 hpf.  (L) 
Diagram of region imaged in J and K.  (M-N) Vibratome section of a wild type (M) or 
mypt1 mutant (N) embryo at 24 hpf.  (O)  Diagram of embryo stage and region imaged in 
M and N. Scale bars=50µM for A-B, G-H, J-K, M-N.  Scale bars=25 µM for D-E. 
 
Fig. 6.  Abnormal rhombomere progression and ventricle expansion in mypt1 
mutants is myosin dependent. (A) Schematic for blebbistatin rescue of the mypt1 
mutant phenotype.  (B) Experimental outline.  Embryos from an mypt1 heterozygous 
cross were sorted at 20 hpf based on an early notochord and somite phenotype in mypt1 
mutants (J. Gutzman, unpublished data). After DMSO control or blebbistatin treatments, 
brains were ventricle injected and imaged.  Representative images from 3 independent 
experiments. (C,D) Dorsal and lateral images of a wild type embryo treated with DMSO 
control, 100% of the embryos looked wild type (n=56/56).  (E,F) Dorsal and lateral 
images of a wild type embryo treated with 50µM blebbistatin.  45% resulted in a slightly 
less inflated ventricle (n=36/80), but all still had normal brain morphology. (G,H) mypt1 
mutant embryo treated with DMSO, 100% had the mutant phenotype (n=22/22).  (I,J) 
mypt1 mutant rescued with blebbistatin, 79% of mutants were rescued (n=33/42).  
Asterisks denote the ear.  Anterior is to the left. 
 
Fig. 7. Abnormal cell shape in mypt1 mutants and rescue with myosin II inhibitor. 
(A) Experimental outline for blebbistatin rescue of cell shape in mypt1 mutants.  1. 
Injection of memGFP mRNA into mypt1 mutant clutch. 2. 17 hpf embryos treated with 
0.1% DMSO or 50µm blebbistatin. 3. Live imaging of the hindbrain by scanning 
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confocal microscopy. 4. PCR identification of wild type and mypt1 mutant embryos 
imaged. (B) Blebbistatin rescue results.  (a) Wild type embryo treated with DMSO, cells 
were outlined and (e) 3D reconstructed. (b) Wild type embryo treated with blebbistatin, 
cells were outlined and (f) 3D reconstructed.  (c) mypt1 mutant treated with DMSO, cells 
were outlined and (g) 3D reconstructed. (d) mypt1 mutant treated with blebbistatin, cells 
were outlined and (h) 3D reconstructed. Images are representative from 3 independent 
experiments.  At least 4 embryos for each treatment group were analyzed for cell shape, 
3-5 cells were outlined from each embryo.  (C) Quantitation of neural tube width at the 
widest region of r4 (or the boundary between r4/r5, Fig. S9 in supplemental material) in 
embryos treated with DMSO or blebbistatin as indicated. (wild type+DMSO n=7, wild 
type+bleb n=8, mypt1+DMSO n=6, mypt1+bleb n=5).   r4, r5 indicate rhombomere 
number. Yellow=rhombomere cells, blue=boundary cells.  Asterisks denote the ear.  
Anterior is to the left.  In C, asterisks indicates that the bar is significantly different from 
all other bars using the Mann-Whitney U test, p<0.01. Scale bars=25µM. 
 
Fig. 8. Model for the requirement of mypt1 in the regulation of myosin during brain 
morphogenesis.  Proposed requirements for Mypt1 during zebrafish brain 
morphogenesis.  Mypt1 is required for proper rhombomeric cell shape at 19 hpf.  It is 
also required later for progression of rhombomere morphology and for brain ventricle 
expansion.  The requirement for Mypt1 during formation of rhombomere morphology 
and during ventricle opening is unclear; however, our data suggest that myosin may be 
required for these earlier steps, which would indicate that Mypt1 inhibition of myosin 
phosphatase may be required during those processes. 
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